Table 3.
Strain | Resistance to β-lactams | Adhesins | DL50 (days) ± SDa
|
Death (days) ± SDa
|
p | ||
---|---|---|---|---|---|---|---|
3Pl (n = 8) | 3UE (n = 8) | 3Pl | 3UE | ||||
NECS20575 | S | papG+/fimH+ | 3.21 ± 0.36 | 5.43 ± 0.22 | 7 ± 0.25 | 9.5 ± 0.25 | <0.001 |
NECS29787 | S | papG+/fimH+ | 3.03 ± 0.22 | 5.11 ± 0.40 | 6.5 ± 0.25 | 9 ± 0.25 | <0.001 |
NEC13 | TEM-3 | papG−/fimH+ | 4.76 ± 0.35 | 5.28 ± 1.24 | 9 ± 0.25 | 10 ± 0.25 | 0.02 |
NEC5 | CTX-M-15 | papG−/fimH− | 5.33 ± 0.15 | 6.21 ± 0.17 | 11 ± 0.25 | 11.5 ± 0.25 | – |
3Pl, regimen with three placebo capsules; 3UE, regimen with three cranberry capsules; DL50, time at which 50% of the worms were killed.
The results are means of at least four independent trials on different days and two independent trials on the same day for each strain.